Expression of toll-like receptors (TLRs) and nucleotide-binding oligomerization domain (NODs) in murine peritoneal macrophages on in vitro treatment with Thymosin α 1

American Journal of Immunology

Volumn 3, Issue 1, 2007, Pages 15-24

  Tarang, Shikha ^a   Sodhi, Ajit ^a  

^a BANARAS HINDU UNIVERSITY   (India)

Author keywords

Cytokines; Macrophages activation; Thymosin 1; TLRs

Indexed keywords

CASPASE RECRUITMENT DOMAIN PROTEIN 15; CYTOKINE; DNA; INTERFERON REGULATORY FACTOR 3; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 1; LIPOPOLYSACCHARIDE; MYELOID DIFFERENTIATION FACTOR 88; THYMOSIN ALPHA1; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 5; TOLL LIKE RECEPTOR 6; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 8; TOLL LIKE RECEPTOR 9; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6; ZYMOSAN;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CPG ISLAND; CYTOKINE PRODUCTION; DOWN REGULATION; FEMALE; IN VITRO STUDY; INCUBATION TIME; MACROPHAGE ACTIVATION; MALE; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PROTEIN DOMAIN; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UPREGULATION; WESTERN BLOTTING;

EID: 44849129723     PISSN: 1553619X     EISSN: None     Source Type: Journal    
DOI: 10.3844/ajisp.2007.15.24     Document Type: Article

References (38)

1. Hoffmann, J.A., F.C. Kafatos, C.A. Janeway and R.A.B. Ezekowitz, 1999. Phylogenetic perspectives in innate immunity. Science, 284 (5418):313-1318.
2. Roach, J.C., G. Glusman, L. Rowen, A. Kaur, M.K. Purcell, K.D. Smith, L.E. Hood and A. Aderem, 2005. The evolution of vertebrate Toll-like receptors. PNAS, 102 (27): 9577-9582.
3. Muzio, M., D. Bosisio, N. Polentarutti, G. D'amico, A. Stoppacciaro, C. van't Veer, G. Penton-Rol, L.P. Ruco, P. Allavena and A. Mantovani, 2000. Differential expression and regulation of toll-like receptors (TLR) in human leukocytes: selective expression of TLR3 in dendritic cells. J. Immunol., 164 (11): 5998-6004.
4. Applequist, S.E., R.P.A. Wallin and H-G Ljunggren, 2001. Variable expression of Toll-like receptors in murine innate and adaptive immune cell lines. Int. Immunol., 14 (9): 1065-1074.
5. Gay N.J., M: Gangloff and N.A. Weber, 2006. Toll-like receptors as molecular switches. Nat. Rev. Immunol., 6(9): 693-698.
6. Bell, J.K., G.E.D. Mullen, C.A. Leifer, A. Mazzoni, D.R. Davies and D.M. Segal, 2003. Leucine- rich repeats and pathogen recognition in Toll-like receptors. Trends Immunol., 24 (10): 528-533.
7. Miggin, S.M. and L.A. O'Neill, 2006. New insights into the regulation of TLR signaling. J. Leuko. Biol., 80 (2): 220-226.
8. O'Neill, L.A. 2006. How Toll-like receptor signal: what we know and what we don't know. Curr. Opin. Immunol., 18(1):3-9.
9. Akira, S., K. Takeda and T. Kaisho, 2001. Toll-like receptors: critical proteins linking innate and acquired immunity. Nat. Immunol., 2 (8):675-680.
10. Beg, A.A. 2002. Endogenous ligands of Toll-like receptors: implications for regulating inflammatory and immune responses. Trends Immunol., 23 (11):509-512.
11. Anderson, K.V. 2000. Toll-signaling pathways in the innate immune response. Curr. Opin. Immunol., 12 (1):13-19.
12. Kammanadiminti, S.J., B.J. Mann, L. Dutil and K. Chadee, 2004. Regulation of Toll-like receptor 2 expression by the Gal-lectin of Entamoeba histolytica. FASEB J., 18 (1):155-157.
13. Chang, J-H, J-Y. Park and S-K. Kim, 2006. Dependence on p38 MAPK signalling in the up-regulation of TLR2, TLR4 and TLR9 gene expression in Trichomonas vaginalis-treated HeLa cells. Immunology, 118 (2): 164-170.
14. Akira, S. S. Uematsu and O. Takeuchi, 2006. Pathogen recognition and Innate Immunity. Cell, 124 (4):783-801.
15. Wang, S.S., H.H. Lee, R.J. Sokol and M.G. Mutchnick, 1980. Automated solid phase synthesis of thymosin α 1. Int. J. Peptide Protein Res., 15 (1): 1-4.
16. Werts, C., S.E. Girardin and D.J. Philpott., 2006. TIR, CARD and PYRIN: three domains for an antimicrobial triad. Cell death and Diff., 13 (5): 798-815.
17. Kim, J.U., S.J. Lee and M.F. Kagnoff, 2004. Nod1 is an essential signal transducer in intestinal epithelial cells infected with bacteria that avoid recognition by Toll-like receptors. Infect. Immun., 72 (3): 1487-1495.
18. Opitz, B., A. Puschel, B. Schmeck, A.C. Hocke, S. Rosseau, S. Hammerschmidt, R.R. Schumann, N. Suttorp and S. Hippenstiel, 2004. Nucloetide-binding oligomerization domain proteins are innate immune receptors for internalized Streptococcus pneumoniae. J. Biol. Chem., 279 (35): 36426-36424.
19. Ferwada, G., S.E. Girardin, B-J. Kullberg, D. de Jong, D.M.L. Lagenberg, R. van Crevel, G.J. Adema, T.H.M. Ottenhoff, J.W.M. van der Meer and M.G. Netea, 2005. Nod2 and TLR2 are two non-redundent recognition systems of mycobacterium tuberculosis. PLoS Pathogens, 1 (3): 280-285.
20. Zhang, P., J. Chan, A-M. Dragoi, X. Gong, S. Ivanov, Z-W. Li, T. Chuang, C. Tuthill, Y. Wan, M. Karin and W-M. Chu, 2005. Activation of IKKby thymosin α1 requires the TRAF6 signaling pathway. EMBO rep., 6 (6):531-537.
21. Romani, L., F. Bistoni, R. Gaziano, S. Bozza, C. Montagnoli, K. Perruccio, L. Pitzurra, S. Bellocchio, A. Velardi, G. Rasi, P. di Franceso and E. Garaci, 2004. Thymosin α1 activates dendritic cells for antifungal Th1 resistance through toll-like receptor signaling. Blood, 103 (11): 4232-4239.
22. Billich, A. 2002. Thymosin alpha 1, SciClone Pharmaceuticals. Curr. Opin. Investig., 3 (5): 698-707.
23. Tarang, S., A. Sodhi and P. Chauhan, 2007. Differential expression of Toll-like Receptors in murine peritoneal macrophages, on in vitro treatment with cisplatin. Int. Immunol., doi:10.1093/intimm/dxm029.
24. Sodhi, A., S. Tarang and V. Kesherwani, 2007. Concanavlin A induced expression of Toll-like Receptors in murine peritoneal macrophages in vitro. Int. Immunophamacol., 7 (4): 454-463.
25. Sodhi, A. and S. Paul, 2002. Involvement of mitogen-activated protein kinases in the signal transduction pathway of bone marrow-derived macrophage activation in response to in vitro treatment with thymosin alpha 1. Int. Immunopharmacol., 2 (1): 47-58.
26. Singh, R.K., A. Sodhi and S.M. Singh, 1991. Production of Interleukin-1 and Tumour Necrosis Factor by cisplatin treated murine peritoneal macrophages. Nat. Immun. Cell Growth Regul., 10 (2):105-116.
27. Wajant, H., F. Henkler and P. Scheurich, 2001. The TNF-receptor-associated factor family: scaffold molecules for cytokine receptors, kinases and their regulators. Cell Signal., 13 (6): 389-400.
28. Nilsen, N., U. Nonstad, N. Khan, C.F. Knetter, S. Akira, A. Sundan, T. Espevik and E. Lien, 2004. Lipopolysaccride and Double-stranded RNA Up regulate Toll-like Receptor 2 Independently of Myeloid Differentiation Factor 88. J. Biol. Chem., 279 (38): 39727-39735.
29. MacKay, R.J., R.R. King, J.R. Dankert, K.J. Reis and L.A. Skelley, 1991. Cytotoxic tumor necrosis factor activity produced by equine alveolar macrophage: preliminary characterization. Vet. Immunol. Immunophthol., 29 (1-2):15-30.
30. Jiang W., J. Li, M. Gallowitsch-Pureta, K.J. Tracey and D.S. Pisetsky, 2005. The effects of CpG DNA on HMGB1 release by murine macrophages cell lines. J. Leuko. Biol., 78 (4): 930-936.
31. Brouet, I and H. Ohshima, 1995. Curcumin, an anti-tumor promoter and anti-inflammatory agent, inhibits induction of nitric oxide synthase in activated macrophages. Biochem and Biophy. Res. Comm., 206 (2): 533-540.
32. Sodhi, A. and G. Sethi, 2003. Involvement of MAP kinase signal transduction pathway in UV-B induced activation of macrophages in vitro. Immunol. Lett., 90 (2-3):123-130.
33. Ding A.H., C.F. Nathan and D.J. Stuecher, 1988. Release of reactive nitrogen intermediate from mouse peritoneal macrophages: comparison of activating cytokines and evidences for independent production. J. Immunol., 14 (7):12407-2412.
34. Katherine, A.F., C.R. Daniel, J.B. Betsy, R.C. Daniel, V. Alberto, L. Eicke, M. Brian, M.P. Paula and T.G. Douglas, 2003. LPS-TLR4 Signaling to IRF-3/7 and NF-κB involves the Toll Adapters TRAM and TRIF. J. Exp. Med., 198 (7):1043-1055.
35. Takeda, K. and S. Akira, 2005. Toll-like receptors in innate immunity. Int. Immunol., 17(1):1-14.
36. Takeda, K. 2005. Toll-like receptors and their adaptors in innate immunity. Curr. Med. Chem., 4 (1):3-11.
37. Wara, D.W., A.L. Goldstein, N.E. Doyle and A.J. Amman, 1975. Thymosin activity in patients with cellular immunodeficiency. N. Engl. J. Med., 292 (2):70-74.
38. Garaci, E., F. Pica, G. Rasi and C. Favalli, 2000. Thymosin alpha 1 in the treatment of cancer: from basic research to clinical application. Int. J. Immunopharmacol., 22 (12):1067-1076.